We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Evaluation of Syncope,Its Diagnosis, Treatment, Outcome and Prognosis (E-STOP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00764985
Recruitment Status : Completed
First Posted : October 2, 2008
Last Update Posted : July 2, 2010
Transoma Medical
Information provided by:
St. Luke's-Roosevelt Hospital Center

Brief Summary:
The investigators want to look at how patients admitted after passing out (syncope) or nearly passing out (pre-syncope) do after going home and how many of them remain free of symptoms of syncope or pre-syncope.

Condition or disease

Study Type : Observational
Estimated Enrollment : 540 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: E-STOP Registry: A Registry for the Evaluation of Syncope,Its Diagnosis, Treatment, Outcome and Prognosis Using Our SELF-Pathway
Study Start Date : June 2008
Primary Completion Date : July 2009
Study Completion Date : July 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Fainting
U.S. FDA Resources


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patietns admitted to the adult medicine service at St. Luke's-Roosevelt Hospital with diagnossi of syncope or near syncope

Inclusion Criteria:

  • All adult patients (age 18 or older) admitted with syncope or near-syncope

Exclusion Criteria:

  • Patients who do not speak/read the language of the consent form
  • Prisoners
  • Patients who are of altered mental status or had head trauma
  • Refusal or inability to sign consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00764985

United States, New York
St. Luke's-Roosevelt Hospital Center
New York, New York, United States, 10025
Sponsors and Collaborators
St. Luke's-Roosevelt Hospital Center
Transoma Medical

Responsible Party: Suneet Mittal, St. Luke's-Roosevelt Hospitals
ClinicalTrials.gov Identifier: NCT00764985     History of Changes
Other Study ID Numbers: ESTOP-08-024
First Posted: October 2, 2008    Key Record Dates
Last Update Posted: July 2, 2010
Last Verified: July 2010

Keywords provided by St. Luke's-Roosevelt Hospital Center:

Additional relevant MeSH terms:
Consciousness Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms